The Role of Erythropoietin in Myelodysplastic Syndrome

Completed

Conditions studied: Myelodysplastic Syndrome

In brief

The purpose of the study is to elucidate the causative molecular events responsible for the abnormal erythropoiesis in MDS.

Key facts

Study ID

NCT00723112

Run by

University of Utah

People needed

8

Starts

2007-02-01

Expected to finish

2010-10-01

Last updated by the study team

2010-11-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult subjects greater than 18 years of age
• Diagnosis of MDS based on the French-American-British classification system (including secondary causes of MDS)

You may not qualify if…

• Subjects not meeting the criteria listed above

Where it is running

• University of Utah — Salt Lake City, Utah, United States
• VA Salt Lake City Health Care System — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.